In The News
NAB super trustee entitled to pay adviser commissions, class action judge says
Dentons says former partner’s equity prospects curtailed by own conduct
Coles, Woolworths say price increases were genuine, and so were the discounts
Start-up denies ex-Fortescue employees developed green iron process on company dime
In class action defence, Toyota says ‘defeat device’ used to protect engines
Hamilton Locke loses challenge to Sydney law firm’s trade mark
Solve My Debt Now to admit liability in ASIC proceedings
Maddocks lures leading competition lawyer from Johnson Winter Slattery
Class action against NAB super fund trustee fails
AI rules to guard against ‘laziness’ in legal profession, top judge says
Please login to bookmarkClose

A judge has found Pfizer’s patent for its post-operative injectable painkiller Dynastat is valid and that Australian drug maker Juno Pharmaceuticals infringed the patent by selling generic versions of the drug in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au